In addition, without methylation in CpG1 or CpG2, GGH mRNA abundances in cells from bone marrow of ALL, AML and idiopathic thrombocytopenic purpura (ITP) control patients are significantly higher than that in peripheral blood of healthy control patients (p<0.05). This evidence concerns the gene GGH and thrombocytopenic purpura.